Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors

NCT03304587
completednot_applicable

Effectiveness of TechCR Among CHD Patients

NCT04862351
completednot_applicable

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

NCT01975363

Clinical Trials (3)

Showing 3 of 3 trials
NCT03304587Not Applicable

Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors

Completed
NCT04862351Not Applicable

Effectiveness of TechCR Among CHD Patients

Completed
NCT01975363Not Applicable

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3